Matches in Wikidata for { <http://www.wikidata.org/entity/Q91724818> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91724818 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91724818 description "scientific article published on 23 April 2019" @default.
- Q91724818 description "wetenschappelijk artikel" @default.
- Q91724818 description "наукова стаття, опублікована 23 квітня 2019" @default.
- Q91724818 name "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 name "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 type Item @default.
- Q91724818 label "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 label "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 prefLabel "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 prefLabel "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 P1433 Q91724818-EEE412C8-A390-4ED2-8E95-514A94A48DF9 @default.
- Q91724818 P1476 Q91724818-B8FFC111-0D22-44C5-8C2E-AC2BD8310A36 @default.
- Q91724818 P2093 Q91724818-3F70BC2E-6CA9-47D6-9583-C12F84C305FF @default.
- Q91724818 P2093 Q91724818-83195854-6E15-455D-A5B5-67401127215C @default.
- Q91724818 P2093 Q91724818-B2F34A92-7863-4F99-9D58-476EEB929BDC @default.
- Q91724818 P2093 Q91724818-BC592337-308C-4E6D-93FF-6DBFDF085463 @default.
- Q91724818 P2093 Q91724818-CAA57138-1B0F-456D-85FE-4C470430BF8E @default.
- Q91724818 P31 Q91724818-60AD09D3-0750-46CB-BD6F-0323986B1702 @default.
- Q91724818 P356 Q91724818-76122771-0C0A-44C0-819B-DCC514A25A5A @default.
- Q91724818 P433 Q91724818-7FB08112-4377-4F54-91FD-D7E9E4A78C1D @default.
- Q91724818 P478 Q91724818-051BAD9B-7F15-4C29-B463-6B3662640255 @default.
- Q91724818 P50 Q91724818-BBF362C0-1AED-49C0-B89D-95E24B0EBC79 @default.
- Q91724818 P577 Q91724818-8F0F4E7D-1060-47C6-9BEB-115199C66646 @default.
- Q91724818 P698 Q91724818-FE7833AD-943C-41A6-87A4-99B49BB49EE8 @default.
- Q91724818 P921 Q91724818-7A25C3B7-C95D-42B3-B8A9-86E7BDD9DF77 @default.
- Q91724818 P356 JCP.18M12546 @default.
- Q91724818 P698 31050233 @default.
- Q91724818 P1433 Q7743563 @default.
- Q91724818 P1476 "Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial" @default.
- Q91724818 P2093 "Christoph U Correll" @default.
- Q91724818 P2093 "Delbert G Robinson" @default.
- Q91724818 P2093 "John M Kane" @default.
- Q91724818 P2093 "Nina R Schooler" @default.
- Q91724818 P2093 "Patricia Marcy" @default.
- Q91724818 P31 Q13442814 @default.
- Q91724818 P356 "10.4088/JCP.18M12546" @default.
- Q91724818 P433 "3" @default.
- Q91724818 P478 "80" @default.
- Q91724818 P50 Q56863506 @default.
- Q91724818 P577 "2019-04-23T00:00:00Z" @default.
- Q91724818 P698 "31050233" @default.
- Q91724818 P921 Q41112 @default.